|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/19 Nymox Pharmaceutical Corp 6-K 6/30/19 40:1.6M Pubco Reporting … Inc/FA |
Document/Exhibit Description Pages Size
1: 6-K Report by a Foreign Issuer HTML 19K
2: EX-99.1 Miscellaneous Exhibit HTML 230K
3: EX-99.2 Miscellaneous Exhibit HTML 21K
4: EX-99.3 Miscellaneous Exhibit HTML 21K
11: R1 Document and Entity Information HTML 27K
12: R2 Consolidated Statements of Operations (Unaudited) HTML 63K
13: R3 Consolidated Statements of Financial Position HTML 74K
14: R4 Consolidated Statements of Financial Position HTML 15K
(Parenthetical)
15: R5 Consolidated Statements of Cash Flows (Unaudited) HTML 66K
16: R6 Consolidated Statements of Changes in Equity HTML 37K
(Unaudited)
17: R7 Basis of preparation HTML 19K
18: R8 Liquidity, Going Concern and Management?s Response HTML 17K
19: R9 Share capital HTML 63K
20: R10 Earnings per share HTML 30K
21: R11 Operating lease and other commitment HTML 31K
22: R12 Related Party Transactions HTML 35K
23: R13 Subsequent events HTML 15K
24: R14 Share capital (Tables) HTML 59K
25: R15 Earnings per share (Tables) HTML 29K
26: R16 Operating lease and other commitment (Tables) HTML 29K
27: R17 Related Party Transactions (Tables) HTML 30K
28: R18 Share capital (Details) HTML 36K
29: R19 Share capital (Details 1) HTML 22K
30: R20 Share capital (Details 2) HTML 19K
31: R21 Share capital (Details Narrative) HTML 39K
32: R22 Earnings per share (Details) HTML 21K
33: R23 Operation lease and other commitment (Details) HTML 16K
34: R24 Operation lease and other commitment (Details 1) HTML 29K
35: R25 Operation lease and other commitment (Details HTML 28K
Narrative)
36: R26 Related Party Transactions (Details) HTML 24K
37: R27 Related Party Transactions (Details Narrative) HTML 27K
39: XML IDEA XML File -- Filing Summary XML 64K
38: EXCEL IDEA Workbook of Financial Reports XLSX 30K
5: EX-101.INS XBRL Instance -- nymx-20190630 XML 468K
7: EX-101.CAL XBRL Calculations -- nymx-20190630_cal XML 78K
8: EX-101.DEF XBRL Definitions -- nymx-20190630_def XML 141K
9: EX-101.LAB XBRL Labels -- nymx-20190630_lab XML 374K
10: EX-101.PRE XBRL Presentations -- nymx-20190630_pre XML 277K
6: EX-101.SCH XBRL Schema -- nymx-20190630 XSD 144K
40: ZIP XBRL Zipped Folder -- 0001640334-19-001644-xbrl Zip 46K
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the period ended June 30, 2019
Commission File Number: 001-12033
Nymox Pharmaceutical Corporation |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): ¨
Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby
furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_____________
Exhibits | |
| |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |||
NYMOX PHARMACEUTICAL CORPORATION |
| ||
(Registrant) | |||
| |||
By: | |||
| |||
| President and Chief Executive Officer | ||
Date: August 14, 2019
3 |
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/14/19 | None on these Dates | ||
| For Period end: | 6/30/19 | |||
| List all Filings | ||||